Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World

NCT06728319 is registered in ClinicalTrials.gov with Biodesix, Inc. as lead sponsor.

NCT NCT06728319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06728319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World
Lead sponsor
Biodesix, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
September 19, 2024
Completion date
July 31, 2027
Enrollment
4,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lung nodules